Sunday, January 22, 2017 11:49:31 AM
This has a long, long way to go IMO. I don't even have a pps I'm aiming for, I'm going to give this a lot of time to develop and let Dr. Jaikaria do his thing.
I'd imagine we'll eventually get some decent wall Street biotech analysts covering this, which is rare for an OTC. For that matter I highly doubt the OTC market is the final destination for this. I have not read anything, as of yet, as to what Dr. Jaikaria's plans are concerning uplisting but I personally feel it's in the cards after what happened with ImmunoCellular Therapeutics.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM